196 related articles for article (PubMed ID: 37335372)
21. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
22. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
23. Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.
Farmer M; Hunt L; Eichenberger MR; Petras RE; Janosky JE; Galandiuk S
Dig Dis Sci; 2001 Mar; 46(3):632-6. PubMed ID: 11318544
[TBL] [Abstract][Full Text] [Related]
24. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
[TBL] [Abstract][Full Text] [Related]
25. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
[TBL] [Abstract][Full Text] [Related]
26. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
[TBL] [Abstract][Full Text] [Related]
27. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.
Clark PM; Dawany N; Dampier W; Byers SW; Pestell RG; Tozeren A
Inflamm Bowel Dis; 2012 Dec; 18(12):2315-33. PubMed ID: 22488912
[TBL] [Abstract][Full Text] [Related]
29. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
Atanassova A; Georgieva A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
[TBL] [Abstract][Full Text] [Related]
30. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.
Ghafouri-Fard S; Eghtedarian R; Taheri M
Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980
[TBL] [Abstract][Full Text] [Related]
31. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
32. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
33. Expression of Cytokine-Coding Genes
Skok DJ; Hauptman N; Jerala M; Zidar N
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680872
[TBL] [Abstract][Full Text] [Related]
34. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
[TBL] [Abstract][Full Text] [Related]
35. LINC00641/miR-378a and Their Cross-Talk with TNF-α/IFN-γ as Potential Biomarkers in Ulcerative Colitis and Crohn's Diseases.
Hameed NAA; Shaker OG; Hasona NA
J Interferon Cytokine Res; 2023 Nov; 43(11):531-537. PubMed ID: 37956249
[TBL] [Abstract][Full Text] [Related]
36. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
Sun Y; Cai D; Hu W; Fang T
Front Genet; 2022; 13():950136. PubMed ID: 36118873
[No Abstract] [Full Text] [Related]
37. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
38. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes.
Lin P; Hua J; Teng Z; Lin C; Liu S; He R; Chen H; Yao H; Ye J; Zhu G
Eur J Med Res; 2023 Jul; 28(1):247. PubMed ID: 37481583
[TBL] [Abstract][Full Text] [Related]
39. Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer.
Pan Z; Lin H; Fu Y; Zeng F; Gu F; Niu G; Fang J; Gu B
Front Immunol; 2023; 14():1086898. PubMed ID: 36742294
[TBL] [Abstract][Full Text] [Related]
40. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
Jabandziev P; Bohosova J; Pinkasova T; Kunovsky L; Slaby O; Goel A
Inflamm Bowel Dis; 2020 Jun; 26(7):985-993. PubMed ID: 32009179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
